P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON
- DOI
- 10.1097/01.hs9.0000971512.00634.8e
- Published
- 2023-08
- Container
- HemaSphere
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/01.hs9.0000971512.00634.8e,
title = {P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON},
author = {Catherine Thieblemont and Christopher Fox and Anthony Wang and Kavita Sail and Abualbishr Alshreef and Michael Moran and Alex Mutebi and Julie Blaedel and Viktor Chirikov and Gilles Salles},
year = {2023},
journal = {HemaSphere},
doi = {10.1097/01.hs9.0000971512.00634.8e},
url = {https://doi.org/10.1097/01.hs9.0000971512.00634.8e}
}RIS
TY - JOUR TI - P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON AU - Catherine Thieblemont AU - Christopher Fox AU - Anthony Wang AU - Kavita Sail AU - Abualbishr Alshreef AU - Michael Moran AU - Alex Mutebi AU - Julie Blaedel AU - Viktor Chirikov AU - Gilles Salles PY - 2023 JO - HemaSphere DO - 10.1097/01.hs9.0000971512.00634.8e UR - https://doi.org/10.1097/01.hs9.0000971512.00634.8e ER -
APA
Thieblemont, C., Fox, C., Wang, A., Sail, K., Alshreef, A., Moran, M., Mutebi, A., Blaedel, J., Chirikov, V., & Salles, G. (2023). P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON. HemaSphere. https://doi.org/10.1097/01.hs9.0000971512.00634.8e
Source records
- crossref · retrieved 2026-09-27T10:51:01.455Z